This time of year signals various tasks – holiday shopping, creating Easter eggs, tending to the lawn for the first time, and engaging in a thorough spring cleaning of the house. In line with this spirit of renewal, why not extend this purging to your investment portfolio by divesting from lackluster stocks?

The present moment offers a prime opportunity to eliminate underperforming stocks from your financial arsenal. 2024 deserves a robust and triumphant strategy, devoid of holdings that are setting you back. Clinging onto weak performers is akin to voluntarily entering a financial quicksand that could swiftly erode your wealth.

With the market showcasing bullish tendencies, holding onto stocks past their prime is akin to squandering the riches that should rightfully be yours at this juncture. It’s imperative to utilize tools like the Portfolio Grader to pinpoint the culprits demanding expulsion from your portfolio.

Lucid Group (LCID)

Recent events may paint a rosy picture, but Lucid Group (NASDAQ:LCID) still grapples with significant challenges. Despite a 6% uptick in the last fortnight, courtesy of a lucrative Saudi funding injection, this electric vehicle purveyor’s future remains cloudy.

The partnership between Lucid and Public Investment Fund’s Ayar Third Investment Company, involving a $1 billion payment for Series A convertible preferred shares, might fuel growth. However, the dilution of LCID stock through these preferred shares, representing 12% of its outstanding shares, is a red flag.

Lucid’s imperatives to scale are evident, especially after delivering a mere 6,000 vehicles in 2023. While the recent rebound might be heartening, a nearly 30% slump in LCID stock value amid 2024’s proceedings still merits an “F” grade from the Portfolio Grader.

Plug Power (PLUG)

Plug Power (NASDAQ:PLUG) boasts a revolutionary battery technology leveraging hydrogen and oxygen to generate electricity, leaving water vapor as its only residue.

Despite these innovative endeavors, Plug Power is engulfed in a profitability conundrum. The latest financials, with earnings touching $198.7 million but the company incurring a whopping $283.4 million loss and an EPS deficit of 47 cents, signify a troubling trajectory.

Support from the U.S. Department of Energy, facilitating a $75.7 million developmental infusion, and purported plans to secure a $1.6 billion government loan facility for liquidity challenges may offer temporary solace. Yet, the narrative surrounding PLUG stock in 2024, down by 23%, steadfastly clings to an “F” grade in the Portfolio Grader.

Himax Technologies (HIMX)

Within the semiconductor sphere, Himax Technologies (NASDAQ:HIMX) embodies a stark portrayal of a company failing to ride the crest of AI-driven semiconductor fervor.

Specializing in display driver integrated circuits crucial for image quality across TVs, tablets, and automotive displays, Himax grapples with a lackluster demand backdrop. The shortfall is manifest in dwindling revenues, with fourth-quarter figures plunging to $227.6 million from $262.2 million the preceding year.

Profits reflect a similar downtrend, with $23.5 million and an EPS of 13 cents, mirroring a stark regression from its prior-quarter figures of $42.1 million and a 24-cent EPS. This unimpressive financial trajectory underscores HIMX’s perilous standing.

Challenges and Triumphs in the Stock Market: A Tale of Four Companies

The Rise and Fall of AMC Entertainment Holdings (AMC)

AMC Entertainment Holdings (NYSE: AMC), once a shining star in the entertainment industry, is now facing turbulent times. The allure of meme stocks has not been enough to shield AMC from the harsh realities of a changing movie landscape.

The advent of streaming services has dealt a severe blow to traditional cinemas. With audiences increasingly opting for the convenience of watching movies from their couches, AMC’s box office revenues have taken a hit. Furthermore, the aftermath of the Writers Guild of America strike has left the company reeling, with only a couple of movies crossing the $100 million mark in domestic sales this year.

To compound AMC’s troubles, the burden of a $4.6 billion long-term debt has left investors jittery. The stock has tumbled by 29% this year, and the Portfolio Grader rates AMC with an “F.”

The Downward Spiral of Mullen Automotive (MULN)

Mullen Automotive (NASDAQ: MULN) finds itself in dire straits, with its stock plunging to penny stock territory below $5 per share. Despite multiple reverse stock splits in 2023, including a drastic 1-for-100 split in December, MULN continues its downward trajectory.

The company’s abysmal performance paints a grim picture, with a staggering decline of over 99% in the last year and a further plummet of 60% in 2024. Even the best quarterly sales, with only 396 vehicles delivered in Q4 2023, couldn’t salvage Mullen from reporting a colossal net loss of $61.4 million.

Pinning its hopes on a shift to commercial electric vehicles, Mullen’s future remains uncertain. The Portfolio Grader’s “F” rating echoes the grim reality facing MULN investors.

The Potential and Predicament of Solid Power (SLDP)

Solid Power (NASDAQ: SLDP) is at the vanguard of developing all-solid-state battery cells, presenting a promising alternative to conventional lithium-ion batteries. The allure of safer, more energy-efficient, and cost-effective batteries for EVs and renewable energy sources beckons.

However, Solid Power’s current predicament lies in its escalating losses, outstripping its revenue growth. Despite a commendable revenue surge to $17.4 million in 2023, up from $11.7 million in 2022, the company incurred substantial losses amounting to $65.5 million for the year.

The company’s outlook for 2024 remains challenging, with projected revenues of $20-25 million against anticipated expenditures of $100-120 million. While the future potential of Solid Power shines bright, caution is warranted for investors as they navigate the company’s financial landscape.

Pfizer (PFE): A Beacon of Stability

Amidst the tumultuous seas of the stock market, Pfizer (NYSE: PFE) stands as a beacon of stability. With a long history of pharmaceutical excellence, Pfizer has weathered various market storms and emerged as a stalwart in the healthcare sector.

While the journey of other companies may be fraught with uncertainties and volatility, Pfizer’s commitment to innovation and patient well-being has ensured its enduring success. Investors seeking a reliable anchor in their portfolios may find solace in Pfizer’s steadfast performance.

Pfizer Stock Forecast: Navigating the Pharmaceuticals Seas After the Mylan Deal

A Steep Climb Ahead for Pfizer Stock

Investors in Pfizer (NYSE: PFE) find themselves in choppy waters despite the company’s recent acquisition of Mylan. The pharmaceutical giant soared to great heights with the development of a widely praised Covid-19 vaccine. However, with the waning demand for vaccinations, Pfizer’s revenue has taken a nosedive. The fourth-quarter of the past fiscal year saw a significant 41% drop in revenue, with income following suit. Despite these drawbacks, Pfizer remains optimistic about its future trajectory.

Weathering the Storm

Pfizer is diligently charting its course for the future, with plans to unveil over a dozen new products within the next 18 months. The recent acquisition of Seagen, a prominent oncology specialist, promises to bolster Pfizer’s revenue stream with four commercially successful oncology products. These strategic moves signify Pfizer’s commitment to diversifying its portfolio and weathering the current market challenges.

Potential Glint on the Horizon

While Pfizer stock might not be the most appealing investment option currently, there is a glimmer of hope on the distant horizon. With a 3% decrease in stock value in 2024 and a lackluster grade from Portfolio Grader, Pfizer is facing an uphill battle. However, with its strategic acquisitions and upcoming product launches, Pfizer might be poised for a resurgence in the near future.

On the publication date of this article, Louis Navellier and the InvestorPlace Research Staff did not hold any positions related to the securities discussed.

Source: Manuel Esteban / Shutterstock.com

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.